Before the COVID-19 pandemic, for-profit nursing homes’ revenue generally covered their costs, whereas not-for-profit nursing homes often needed donations and other nonpatient revenue to cover ...
Biosimilars present a key opportunity to contain the growing cost of biologic drug spending and to make essential medications more affordable. However, the lackluster performance of the US biosimilar ...
The NIH’s current system for funding scientific research perpetuates health disparities by privileging established, well-resourced institutions and reinforcing an individual-level focus on disease ...
The policies proposed by Project 2025, if implemented, could fundamentally reshape not only the landscape of reproductive ...
Instead of abolishing health savings accounts, we could turn them into vehicles for patients to get more cost-effective, ...
Regulation of health system consolidation should take into account all aspects of the market for health care goods and ...
The sweeping relief sought by plaintiffs could erode protections for consumers against unanticipated financial liabilities ...
The convergence of uninsured adults without access to vaccination services, mis/disinformation, and partisan politics translates to tangible outcomes including a dip in kindergarten vaccination rates; ...
Health Affairs' Editor-in-Chief Alan Weil interviews Naomi Zewde of the University of California, Los Angeles about her recent paper exploring how high-deductible health insurance plans may exacerbate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback